Cardiology

Protein inhibitor holds promise for heart disease treatment

UC Davis scientists have developed a novel cardiovascular agent which, unlike currently available drugs for heart disease, does not target high blood cholesterol or high blood pressure. The experimental agent inhibits C-reactive ...

Diseases, Conditions, Syndromes

Novel drug acts in unique way to protect against kidney injury

New research reveals the mechanism by which an experimental drug can protect the kidneys from sudden damage, called acute kidney injury (AKI). The findings, which appear in an upcoming issue of the Journal of the American ...

Medications

Rival obesity drugs seek out patients, and acceptance

Between 1999 and 2012, the Food and Drug Administration gave its blessing to exactly zero new weight-loss drugs. Then, starting in June of last year, the agency approved two such medications, in a span of 20 days.

Other

AstraZeneca to pay about $260M for Omthera Pharma (Update 2)

British drugmaker AstraZeneca PLC plans to spend about $260 million on Omthera Pharmaceuticals Inc., a specialty drug developer with only 14 employees but has a potential treatment for patients who have high levels of fats ...

Medical research

Four genes indentified that influence levels of 'bad' cholesterol

Scientists at the Texas Biomedical Research Institute in San Antonio have identified four genes in baboons that influence levels of "bad" cholesterol. This discovery could lead to the development of new drugs to reduce the ...

page 11 from 22